Proteolix

📍 SSF, United States🗓 Founded 2003👥 13 employees💰 Last funded Jun 2006
Biotechnology Research🌐 proteolix.com
Website LinkedIn
Not sure what to write? Check out your company's website.Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers and immunological conditions by inhibiting the proteasome and thereby disrupting protein turnover in cells. In addition to its lead product candidate, carfilzomib (PR-171), which is delivered intravenously and is currently in multiple clinical trials to evaluate its safety and efficacy in multiple types of cancer, Proteolix is developing next generation proteasome inhibitors, including an oral proteasome inhibitor and a selective immunoproteasome inhibitor, to expand the therapeutic potential of this new target class. Proteolix is headquartered in South San Francisco.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2003
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Proteolix?
Proteolix has 1 investors on record on gritt.io, 1 mid-stage.
When did Proteolix last raise funding?
The most recent investment in Proteolix recorded on gritt.io was in June 2006.
When was Proteolix founded?
Proteolix was founded in 2003.
What industry is Proteolix in?
Proteolix operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Proteolix based?
Proteolix is headquartered in SSF, United States.